via Michigan State University
Michigan State University and Stanford University scientists have invented a nanoparticle that eats away – from the inside out – portions of plaques that cause heart attacks.
Bryan Smith, associate professor of biomedical engineering at MSU, and a team of scientists created a “Trojan Horse” nanoparticle that can be directed to eat debris, reducing and stabilizing plaque. The discovery could be a potential treatment for atherosclerosis, a leading cause of death in the United States.
The results, published in the current issue of Nature Nanotechnology, showcases the nanoparticle that homes in on atherosclerotic plaque due to its high selectivity to a particular immune cell type – monocytes and macrophages. Once inside the macrophages in those plaques, it delivers a drug agent that stimulates the cell to engulf and eat cellular debris. Basically, it removes the diseased/dead cells in the plaque core. By reinvigorating the macrophages, plaque size is reduced and stabilized.
Smith said that future clinical trials on the nanoparticle are expected to reduce the risk of most types of heart attacks, with minimal side effects due to the unprecedented selectivity of the nanodrug.
Smith’s studies focus on intercepting the signaling of the receptors in the macrophages and sending a message via small molecules using nano-immunotherapeutic platforms. Previous studies have acted on the surface of the cells, but this new approach works intracellularly and has been effective in stimulating macrophages.
“We found we could stimulate the macrophages to selectively eat dead and dying cells – these inflammatory cells are precursor cells to atherosclerosis – that are part of the cause of heart attacks,” Smith said. “We could deliver a small molecule inside the macrophages to tell them to begin eating again.”
This approach also has applications beyond atherosclerosis, he added.
“We were able to marry a groundbreaking finding in atherosclerosis by our collaborators with the state-of-the-art selectivity and delivery capabilities of our advanced nanomaterial platform. We demonstrated the nanomaterials were able to selectively seek out and deliver a message to the very cells needed,” Smith said. “It gives a particular energy to our future work, which will include clinical translation of these nanomaterials using large animal models and human tissue tests. We believe it is better than previous methods.”
Smith has filed a provisional patent and will begin marketing it later this year.
A link to the original paper: https://www.nature.com/articles/s41565-019-0619-3
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
Trojan Horse nanoparticle
- Comparing COVID-19 vaccines: How are they different?on February 26, 2021 at 6:34 am
Even if you're still waiting for a vaccine, watching the first people get their COVID-19 vaccinations may have felt like a huge relief. As the weeks pass, countless reports are coming out about the ...
- Nanobiotechnology-Based Strategies for Crossing the Blood–Brain Barrieron February 21, 2021 at 4:00 pm
Several nanoparticles (NPs ... NPs for enhancing monoclonal antibody delivery across the BBB by the Trojan horse approach, use of peptide–NP conjugates and two commercial technologies ...
- COVID-19: The single-shot Janssen vaccine could be a gamechanger in the fight against the pandemicon February 11, 2021 at 4:48 am
That means an adenovirus (which causes the common cold) works like a Trojan horse to carry the genetic ... These are harvested and assembled into nanoparticles to make the vaccine formulation.
- Gastric Cancer News and Researchon February 10, 2021 at 4:00 pm
Cancer cells are killed in lab experiments and tumour growth reduced in mice, using a new approach that turns a nanoparticle into a 'Trojan horse' that causes cancer cells to self-destruct ...
- Nanoparticle eats away at plaque in arterieson January 27, 2021 at 4:00 pm
A new “Trojan Horse” nanoparticle can eat away portions of the plaques that cause heart attacks, research in mice indicates. The discovery could be a potential treatment for atherosclerosis ...
Go deeper with Google Headlines on:
Trojan Horse nanoparticle
Go deeper with Bing News on:
Atherosclerosis
- Atherosclerosis can accelerate the development of clonal hematopoiesis, study findson February 26, 2021 at 12:55 pm
Billions of peripheral white blood cells are produced every day by the regular divisions of hematopoietic stem cells and their descendants in the bone marrow. Under normal circumstances, thousands of ...
- Impact of cigarette versus electronic cigarette aerosol conditioned media on aortic endothelial cells in a microfluidic cardiovascular model | Scientific Reportson February 26, 2021 at 10:02 am
Atherosclerosis is a complex process involving progressive pathological events, including monocyte adhesion to the luminal endothelial surface. We have developed a functional in vitro adhesion assay ...
- Scientists investigate mechanisms by which hypertension leads to atherosclerosison February 25, 2021 at 6:04 pm
Research scientists at Aarhus University and Aarhus University Hospital have investigated the mechanisms by which hypertension leads to arterial damage and atherosclerosis. The results may facilitate ...
- Researchers identify a new mechanism underlying atherosclerosison February 25, 2021 at 4:48 pm
Glycomics researchers at the University of Alberta and CHU Sainte-Justine have reported a discovery that could lead to new treatments for cardiovascular disease.
- How hypertension leads to atherosclerosison February 25, 2021 at 8:08 am
Research scientists at Aarhus University and Aarhus University Hospital have investigated the mechanisms by which hypertension leads to arterial damage and atherosclerosis. The results may facilitate ...